Review of Answers
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sample Research Poster
Surgical management and lymph node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients Amrita Goyal MD, 1 Theodore Marghitu,2 Nikhil Goyal BS,3 Nathan Rubin MS,4 Krishnan Patel MD,6 Kavita Goyal MD,1 Daniel O’Leary MD,5 Kimberly Bohjanen MD, 1 Ian Maher MD 1 1Department of Dermatology, University of Minnesota, Minneapolis, MN 2University of Minnesota Medical School, Minneapolis, MN 3National Institutes of Health/National Cancer Institute, Bethesda, MD 4Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis MN 5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 6Department of Radiation Oncology, University of Minnesota, Minneapolis, MN Background Overall and Disease-Specific Survival Lymph Node Biopsy and Survival Cutaneous adnexal carcinomas comprise a group of Vital status* All Sweat Hidradenocarc Spiradenocarci Sclerosin Porocarcin Eccrine Sebaceous Lymph Nodes All adnexal tumors adnexal gland inoma noma g sweat oma adenocarci carcinoma Lymph Nodes Examined carcino duct noma Nodes not examined 6592 (91.9) rare cutaneous malignancies that are generally ma tumor Nodes examined 578 (8.1) (MAC) Positive (% of examined) 138 (23.9) considered non-aggressive. Guidelines for the Stage (Derived AJCC N=1863 N=70 N=127 N=46 N=236 N=229 N=187 N=968 Negative (% of examined) 440 (76.1) Stage Group, 6th ed treatment of many of these malignancies are sparse, (2004-2015) Total N=1221 5-year OS 5-year DSS 1,2 I 1221 40 (57.1) 56 (44.1) 14 (30.4) 150 140 (61.1) 103 (55.1) 718 (74.2) Stage I Examined N=112 including guidance on surgical management (65.5) (63.6) Nodes not examined (% of total) 1109 (90.8) 69.7 (66.1-72.4) 99.3 (99.6-100) 3,4 II 440 14 (20.0) 54 (47.5) 28 (60.9) 47 (19.9) 64 (27.9) 51 (27.3) 182 (18.8) Nodes positive (% of examined) 0 (0) -- -- including the utility of lymph node biopsy. -
Lysochrome Dyes Sudan Dyes, Oil Red Fat Soluble Dyes Used for Biochemical Staining of Triglycerides, Fatty Acids, and Lipoproteins Product Description
FT-N13862 Lysochrome dyes Sudan dyes, Oil red Fat soluble dyes used for biochemical staining of triglycerides, fatty acids, and lipoproteins Product Description Name : Sudan IV Other names: Sudan R, C.I. Solvent Red 24, C.I. 26105, Lipid Crimson, Oil Red, Oil Red BB, Fat Red B, Oil Red IV, Scarlet Red, Scarlet Red N.F, Scarlet Red Scharlach, Scarlet R Catalog Number : N13862, 100g Structure : CAS: [85-83-6] Molecular Weight : MW: 380.45 λabs = 513-529 nm (red); Sol(EtOH): 0.09%abs =513-529nm(red);Sol(EtOH):0.09% S:22/23/24/25 Name : Sudan III Other names: Rouge Sudan ; rouge Ceresin ; CI 26100; CI Solvent Red 23 Catalog Number : 08002A, 25g Structure : CAS:[85-86-9] Molecular Weight : MW: 352.40 λabs = 513-529 nm (red); Sol(EtOH): 0.09%abs =503-510nm(red);Sol(EtOH):0.15% S:24/25 Name : Sudan Black B Other names: Sudan Black; Fat Black HB; Solvent Black 3; C.I. 26150 Catalog Number : 279042, 50g AR7910, 100tests stain for lipids granules Structure : CAS: [4197-25-5] S:22/23/24/25 Molecular Weight : MW: 456.54 λabs = 513-529 nm (red); Sol(EtOH): 0.09%abs=596-605nm(blue-black) Name : Oil Red O Other names: Solvent Red 27, Sudan Red 5B, C.I. 26125 Catalog Number : N13002, 100g Structure : CAS: [1320-06-5 ] Molecular Weight : MW: 408.51 λabs = 513-529 nm (red); Sol(EtOH): 0.09%abs =518(359)nm(red);Sol(EtOH): moderate; Sol(water): Insoluble S:22/23/24/25 Storage: Room temperature (Z) P.1 FT-N13862 Technical information & Directions for use A lysochrome is a fat soluble dye that have high affinity to fats, therefore are used for biochemical staining of triglycerides, fatty acids, and lipoproteins. -
第32回日本皮膚病理組織学会学術大会 診断投票結果 口演 1 Drug Eruption 13, うち Erythema Multif
第32回日本皮膚病理組織学会学術大会 診断投票結果 口演 1 Drug eruption 13, うち erythema multiforme 1, Interface dermatitis 1, GVHD type 1 Cutaneous reaction due to CCR4 3, うち Dysplastic epidermal hyperplasia 2, Adverse reaction 1 Erythema multiforme 3 PLEVA 1 Vacuolar type interface dermatitis 1 口演 2 Syringofibroadenoma 15, うち + amyloid 1 Syringofibroadenoma with BCC 5 Basal cell carcinoma 4, うち Pinkus type of BCC with syringofibroadenoma 2 口演 3 Darier disease 5 Hailey-Hailey disease 4 Pemphigus 3, うち Pemphigus Vegetans 1, Neonatal pemphigus 1 Grover's disease 4 Epidermal nevus 5, うち Acantholytic (dyskeratotic) epidermal nevus 4, Linear epidermal nevus 1 口演 4 Hydradenoma 13, うち Clear cell hidradenoma 12, Nodular hidradenoma 1 Sebaceous adenoma 1 Trichilemmoma 1 Metastatic tumor 8, うち ~ renal carcinoma6, ~ Clear cell carcinoma 2 口演 5 Apocrine carcinoma 3, うち ~with pagetoid spreading 2 Ectopic breast carcinoma(invasive ductal type)with pagetoid phenomenon 2 Extramammary Paget's disease 12, うち Paget carcinoma 3, ~ with Apocrine adenoma 2, ~ with Tubular adenoma 1, Invasive ~ 1, +Skin metastasis 1, With syringoma 1, with Microcystic Adnexal Carcinoma 1 Syringomatous carcinoma 2, うち ~with paget phenomenon 1 Tubular adenocartinoma 1 Tubular (apocrine) adenoma 2 Syringoma 1 口演 6 Dermatofibroma 10, うち Lipidized ~ 3, Hemosiderotic deep cellular ~ 2, Xanthomatous ~ 1, ~ Histiocytoid variant 1 Fibous histiocytoma 8, うち Atypical ~ 3, Malignant ~ 2, Aneurismal ~ 2 Undifferentiated pleomorphic sarcoma 2 Progressive nodular histiocytosis 1 Squamous -
An Institutional Experience
Original Research Article Skin Adnexal Tumors- An Institutional Experience 1 2* 3 4 5 6 Rekha M Haravi , Roopa K N , Priya Patil , Rujuta Datar , Meena N Jadhav , Shreekant K Kittur 1,5Associate Professor, 2Post Graduate Student, 3,4Assistant Professor, 6Professor & HOD, Department of Pathology, Belgaum Institute of Medical Sciences Dr B R Ambedkar Road, Belagavi, Karnataka – 590001, INDIA. Email: [email protected] Abstract Background: Skin adnexal tumors are a wide spectrum of benign and malignant tumors that differentiate towards one or more adnexal structures found in normal skin. The adnexal structures of skin are the hair follicles, sebaceous glands, eccrine and apocrine sweat glands. These skin adnexal tumors are often difficult to diagnose clinically. This retrospective study was undertaken to know the various histomorphological patterns of skin adnexal tumors at our institution and to determine the incidence among the genders and age groups along with the site distribution. Materials and methods: A total of 40 specimens received and diagnosed as skin adnexal tumors in the department of Pathology at Belgaum Institute of Medical Sciences, Belagavi for a period of 6 years from January 2014 to December 2019 were taken for the study. Histopathological slides prepared from tissue blocks retrieved from departmental archives were reviewed and classified according to the WHO classification 2017. Results: Out of the total 40 samples, benign tumors were 36 (90%) and malignant were 4 (10%). Largest group was the benign tumors of apocrine and eccrine differentiation (47.5%) followed by benign tumors of hair follicle differentiation (40%). Malignant tumors of sebaceous differentiation were 5%, malignant tumors of eccrine and apocrine differentiation were 2.5% and malignant hair follicle differentiation tumors were 2.5% of the total. -
A Rare Clinical Presentation of Desmoplastic Trichilemmoma
Revista5Vol89ingles_Layout 1 8/8/14 10:17 AM Página 796 796 CASE REPORT s A rare clinical presentation of Desmoplastic Trichilemmoma mimicking Invasive Carcinoma* Daniela Tiemi Sano1 Jeane Jeong Hoon Yang1 Antonio José Tebcherani1 Luiz Arthur de Paula Machado Bazzo1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143095 Abstract: Trichilemmoma is a benign neoplasm from the outer sheath of the pilosebaceous follicle. Desmoplastic trichilemmoma, a rare variant, is histologically characterized by a central area of desmoplasia that can clinically mimic an invasive carcinoma, requiring histopathological examination to define the diagnosis. Keywords: Hair diseases; Hair follicle; Skin neoplasms INTRODUCTION The trichilemmoma is a benign solid tumor ori- ma, without the presence of malignant processes, and ginating from external sheath cells of pilosebaceous associated with nevus sebaceous of Jadassohn in the follicles, and the desmoplastic trichilemmoma is a rare periphery of the lesion (Figures 3, 4, 5 and 6). Patient benign histological variant.1,2,3 Clinically, it may look is still under outpatient follow-up, with good clinical like other cutaneous lesions.2 Among the differential evolution and no relapse of lesion. diagnoses, we can cite basal-cell carcinoma, squamous cell carcinoma and viral lesions; the histopathological DISCUSSION examination is necessary for diagnostic confirmation. The trichilemmoma is a benign tumor origina- We report here a case of desmoplastic trichilemmoma ting from external root sheath cells of pilosebaceous in a -
Pdf 344.65 K
Differential Diagnosis of Basal Cell Carcinoma and Benign Tumors of Hair Follicles Using CD34 RESEARCH COMMUNICATION Differential Diagnosis of Basal Cell Carcinoma and Benign Tumors of Cutaneous Appendages Originating from Hair Follicles by Using CD34 Demet Sengul1, Ilker Sengul2*, Muzeyyen Hesna Astarci3, Huseyin Ustun3, Gamze Mocan4 Abstract Background and Aims: Differential diagnosis of the group of benign trichoblastomas, trichofolliculomas, trichoadenomas and trichoepitheliomas, and basal cell carcinomas (BCCs) is troublesome for the clinician as well as the pathologist, especially when only small biopsy specimens are available. Here we investigated whether CD34 expression might be of assistance. Methods: Thirty benign tumors of cutaneous appendages originating from hair follicles (BTCOHF) and 30 BCCs were retrieved from our archives and immunohistochemically stained. CD 34 expression was graded from [0] to [2+] and compared among the groups and subgroups. Results: There was no significant difference between the degree of expression between [0] and [1+] and [0] and [2+] for each group. However, [1+] and [2+] immunopositivity of BTCOHFs was significantly stronger than in BCCs (p= 0.014). Conclusions: CD34 may contribute to differential diagnosis of skin lesions. Keywords: Basal cell cancer - hair follicle lesions - CD 34 immunohistochemistry Asian Pacific J Cancer Prev, 11, 1615-1619 Introduction in 1958. TAs occur as a nodular lesion usually on the face and buttocks (Rahbari et al., 1977, Swaroop et al., 2008) Ackerman et al classified benign tumors of cutaneous and have a variant of verrucous TA mimicing seboreic appendages originating from hair follicle (BTCOHF)’s keratosis. using eight textbooks of dermatopathology in 2001 as Trichoepithelioma (TE) is a benign skin tumor with germ tumors of hair follicle and hamartomas, infindubular follicular differentiation determined in the classification and isthmic tumors, tumors of external layer, tumors of WHO as the synonym of TB (Cotton, 1991). -
Inherited Skin Tumour Syndromes
CME GENETICS Clinical Medicine 2017 Vol 17, No 6: 562–7 I n h e r i t e d s k i n t u m o u r s y n d r o m e s A u t h o r s : S a r a h B r o w n , A P a u l B r e n n a n B a n d N e i l R a j a n C This article provides an overview of selected genetic skin con- and upper trunk. 1,2 These lesions are fibrofolliculomas, ditions where multiple inherited cutaneous tumours are a cen- trichodiscomas and acrochordons. Patients are also susceptible tral feature. Skin tumours that arise from skin structures such to the development of renal cell carcinoma, lung cysts and as hair, sweat glands and sebaceous glands are called skin pneumothoraces. 3 appendage tumours. These tumours are uncommon, but can Fibrofolliculomas and trichodiscomas clinically present as ABSTRACT have important implications for patient care. Certain appenda- skin/yellow-white coloured dome shaped papules 2–4 mm in geal tumours, particularly when multiple lesions are seen, may diameter (Fig 1 a and Fig 1 b). 4 These lesions usually develop indicate an underlying genetic condition. These tumours may in the third or fourth decade.4 In the case of fibrofolliculoma, not display clinical features that allow a secure diagnosis to be hair specific differentiation is seen, whereas in the case of made, necessitating biopsy and dermatopathological assess- trichodiscoma, differentiation is to the mesodermal component ment. -
Rippled-Pattern Sebaceoma: a Report of a Lesion on the Back with a Review of the Literature
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Fukui Repository Rippled-pattern sebaceoma: A report of a lesion on the back with a review of the literature Takahiro Kiyohara, M.D., Masanobu Kumakiri, M.D., Hiroaki Kuwahara, M.D., Atsuko Saitoh, M.D., and Shinichi Ansai, M.D. Department of Dermatology (T.K., M.K.), University of Fukui, Fukui; Division of Plastic Surgery (H.K.), Obihiro-Kousei General Hospital, Obihiro: Sapporo Institute for Dermatopathology (S.A.), Sapporo, Japan Address correspondence and reprint requests to: Takahiro Kiyohara, M.D. Department of Dermatology, University of Fukui 23-3 Shimoaizuki, Matsuoka-cho, Yoshida-gun, Fukui 910-1193, Japan Tel: +81 776 61 3111 Fax: +81 776 61 8112 e-mail: kiyo @ fmsrsa.fukui-med.ac.jp Abstract A 68-year-old Japanese man presented with a tumor that had been present for 5 to 6 years on the right back. Physical examination revealed a dome-shaped, 12x13-mm, dark red tumor. The tumor was excised with a 2 to 3-mm margin. The patient has remained free of disease during 77-months of follow-up. Microscopic examination revealed a bulb-like tumor in the dermis, contiguous with the overlying epidermis. It was composed of small, monomorphous, cigar-shaped basaloid cells in linear, parallel rows, resembling the palisading of nuclei of Verocay bodies, and presenting a rippled-pattern. There were scattered cells showing sebaceous differentiation with vacuolated cytoplasm and scalloped nuclei. There were tiny, duct-like spaces. The tumor revealed characteristics of rippled-pattern sebaceoma. -
Nevus Sebaceus with Syringocystadenoma
UC Davis Dermatology Online Journal Title Nevus sebaceus with syringocystadenoma papilliferum, prurigo nodularis, apocrine cystadenoma, basaloid follicular proliferation, and sebaceoma: case report and review of nevus sebaceus-associated conditions Permalink https://escholarship.org/uc/item/85k968bk Journal Dermatology Online Journal, 26(2) Authors Basu, Pallavi Erickson, Christof P Calame, Antoanella et al. Publication Date 2020 DOI 10.5070/D3262047411 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 26 Number 2| February 2020| Dermatology Online Journal || Case Report 26(2):5 Nevus sebaceus with syringocystadenoma papilliferum, prurigo nodularis, apocrine cystadenoma, basaloid follicular proliferation, and sebaceoma: case report and review of nevus sebaceus-associated conditions Pallavi Basu1 MPH, Christof P Erickson2 MD, Antoanella Calame2 MD, and Philip R Cohen3,4 MD Affiliations: 1School of Medicine, University of California San Diego, La Jolla, California, USA, 2Compass Dermatopathology, San Diego, California, USA, 3San Diego Family Dermatology, National City, California, USA, 4Touro California College of Osteopathic Medicine, Vallejo, California, USA Corresponding Authors: Pallavi Basu, MPH, 8528 Via Mallorca, Apartment G, La Jolla, CA 92037, Tel: 818-917-1786, Email: [email protected]; Philip R. Cohen MD, 10991 Twinleaf Court, San Diego, CA 92131, Email: [email protected] with nevus sebaceus who not only developed Abstract syringocystadenoma papilliferum but also prurigo Nevus sebaceus is a benign skin hamartoma of nodularis in the inferior portion of her lesion is congenital onset that grows during puberty, and in described. Complete excision of the residual nevus adulthood can develop secondary benign and sebaceus also revealed three concurrent additional malignant neoplasms. -
OPTIMISATION of PROTOCOLS for DETECTION of FREE CHOLESTEROL and NIEMANN-PICK TYPE C 1 and 2 PROTEIN Linda M. Scott Biomedical Sc
1 OPTIMISATION OF PROTOCOLS FOR DETECTION OF FREE CHOLESTEROL AND NIEMANN-PICK TYPE C 1 AND 2 PROTEIN Linda M. Scott Biomedical Science May 2010 School of Biological Sciences BMC, Uppsala University Dublin Institute of Technology Department of Medical Biochemistry Kevin Street and Microbiology 2 ABSTRACT The purpose of this project was to optimise the protocols for detection of free cholesterol and NPC 1 and NPC 2 proteins. Paraffin embedded human and rat tissues, cellblocks and cytospins of HepG2 and HeLa cells were used for immunohistochemistry to try out the best antibody dilutions and unmasking method of the antigen. Adrenal tissue was used to stain lipids with Filipin. The dilution that worked best for the NPC 1 was 1:150 and with EDTA unmasking. For the NPC 2 the dilution 1:100 was optimal and with Citrate as unmasking method. NPC 1 was highly expressed in ovary tissue, stomach epithelium, HeLa cells and rat kidney and liver, while NPC 2 was highly expressed in neurons and astrocytes in Alzheimer’s disease, seminiferous tubules in testis, neurons in intestine, neurons in healthy brain tissue and HeLa cells. The cholesterol inducing chemical U18666A was applied to HepG2 cells but no alteration in lipid staining was observed and NPC protein expression was similar at all doses applied. Filipin staining worked well with a concentration of 250µg/mL and Propidium Iodide with concentration 1mg/mL for nuclei stain was optimised at 1:1000.The fixation of cells before lipid stain and immunoperoxidase staining has to be evaluated further as the fixations used, 10% formalin and acetone, had adverse effects on the antigen. -
2016 Essentials of Dermatopathology Slide Library Handout Book
2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass. -
Preclinical Studies of the First in Human Sarna Drug Candidate for Liver Cancer
Oncogene (2018) 37:3216–3228 https://doi.org/10.1038/s41388-018-0126-2 ARTICLE Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer 1 2 2 3 4 1 Vikash Reebye ● Kai-Wen Huang ● Vivian Lin ● Sheba Jarvis ● Pedro Cutilas ● Stephanie Dorman ● 5 1 5 6,7 1 1 Simona Ciriello ● Pinelopi Andrikakou ● Jon Voutila ● Pal Saetrom ● Paul J. Mintz ● Isabella Reccia ● 8 9 5 10 5 1 John J. Rossi ● Hans Huber ● Robert Habib ● Nikos Kostomitsopoulos ● David C. Blakey ● Nagy A. Habib Received: 2 July 2017 / Revised: 2 December 2017 / Accepted: 12 December 2017 / Published online: 7 March 2018 © The Author(s) 2018. This article is published with open access Abstract Liver diseases are a growing epidemic worldwide. If unresolved, liver fibrosis develops and can lead to cirrhosis and clinical decompensation. Around 5% of cirrhotic liver diseased patients develop hepatocellular carcinoma (HCC), which in its advanced stages has limited therapeutic options and negative survival outcomes. CEPBA is a master regulator of hepatic function where its expression is known to be suppressed in many forms of liver disease including HCC. Injection of MTL-CEBPA, a small activating RNA oligonucleotide therapy (CEBPA-51) formulated in liposomal nanoparticles 1234567890();,: 1234567890();,: (NOV340- SMARTICLES) upregulates hepatic CEBPA expression. Here we show how MTL-CEBPA therapy promotes disease reversal in rodent models of cirrhosis, fibrosis, hepatosteatosis, and significantly reduces tumor burden in cirrhotic HCC. Restoration of liver function markers were observed in a carbon-tetrachloride-induced rat model of fibrosis following 2 weeks of MTL-CEBPA therapy.